Ulf Hannelius

No más puestos en curso

Fortuna: 49 548 $ al 31/08/2026

51 años

13 relaciones

Consumer Services

Health Technology

Technology Services

Perfil

Ulf Hannelius is currently Chairman at Diamyd Biomanufacturing AB and Director at Mainly AB since 2021.
Formerly, Dr. Hannelius was President & Chief Executive Officer at Diamyd Medical AB from 2016 to 2026.
Education includes a doctorate from Karolinska Institutet and an MBA from Stockholm School of Economics.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
DIAMYD MEDICAL AB CLASS B 0,31 %	31/08/2025	463.973 ( 0,31 % )	49 548 $	31/08/2026

Cargos activos de Ulf Hannelius

Empresas	Cargo	Inicio
Mainly AB Mainly AB Packaged SoftwareTechnology Services Develops an AI research engineer platform	Director/Miembro de la Junta	22/02/2021

Todos los cargos activos de Ulf Hannelius

Antiguos cargos conocidos de Ulf Hannelius.

Empresas	Cargo	Fin
DIAMYD MEDICAL AB	Director Ejecutivo	22/04/2026

Ver el detalle de la experiencia de Ulf Hannelius.

Formación de Ulf Hannelius.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Ulf Hannelius.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stockholm School of Economics Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Diamyd Medical AB Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes	Health Technology
Mainly AB Mainly AB Packaged SoftwareTechnology Services Develops an AI research engineer platform	Technology Services